TOP 10 Stony brook health studies in Port Jefferson Station, New York

Dr. Robert Hendler, MD is a reputable physician located at 49 Nesconset Highway, Port Jefferson Station, New York, United States. Dr. Hendler received his medical degree from St. George’s University of Medicine and completed his residency in internal medicine and fellowship in hematology and oncology at Stony Brook University Hospital. With a strong dedication to research, Dr. Hendler has been involved in various studies, including investigating the role of probiotics in colorectal cancer patients and analyzing the adverse effects of Ipilimumab. He has also implemented quality improvement measures to enhance patient care. Dr. Hendler is experienced in current hypertension management strategies in diabetic patients and strives to provide the best possible care for his patients. In his free time, he enjoys hiking, cooking, swimming, reading literature, and meditating. Dr. Hendler is board certified in internal medicine and has numerous publications to his name.

Noshir DaCosta, MD is a prestigious medical institution located at 49 New York 347, Port Jefferson Station, New York, United States. Dr. Noshir DaCosta is a highly skilled and experienced Board Certified Physician in Internal Medicine, Medical Oncology, and Hematology. He obtained his Medical Degree from Seth G.S. Medical School, University of Bombay, India, and completed his Internship and Residency in Internal Medicine at LaGuardia Hospital, New York. Dr. DaCosta further specialized in Medical Oncology and Hematology through a Fellowship at SUNY Stony Brook, University Hospital. Dr. DaCosta is a published author in the fields of Hematology and Oncology, with numerous studies featured in peer-reviewed medical journals. He has also served as a lecturer in Clinical Pharmacology and Cancer Biology at the University at Stony Brook School of Medicine, where he currently holds the position of Clinical Assistant Professor of Medicine at University Hospital Stony Brook. Dr. DaCosta's expertise extends to being an Institutional Principal Investigator for NSABP breast cancer protocols.